Macular Disease Foundation Australia logo

    Research news

    Research News

    The latest funding round now brings MDFA’s commitment to macular disease research to $6.9 million across 42 projects since 2011.

    Read more

    Most recent

    2025 Research Grant Recipient  

    Nocturnal hypoxia: An unrecognised risk factor for neovascular age-related macular degeneration

    2025 Grant Family Fund Award Recipient

    Macular vascular disease: software standardisation and data harmonisation to accelerate the development of new imaging biomarkers and therapies

    2025 Grant Family Fund Award Recipient

    Next-generation gene therapy for Stargardt Disease: Enhanced AAV-mediated ABCA4 delivery to restore vision

    $1 million investment in new macular disease research 

    MDFA is Australia’s largest source of research funding in the field of macular disease outside of government.

    MDFA invests $1 million into macular disease research

    Macular Disease Foundation Australia today announced it has awarded more than $1 million to eight

    MDFA launches $200,000 grant for geographic atrophy research

    Macular Disease Foundation Australia (MDFA) has announced the launch of its inaugural MDFA 25th Anniversary Award

    MDFA showcases groundbreaking research projects in new impact report

    Macular Disease Foundation Australia (MDFA) has launched its new Research Impact Report, which showcases the groundbreaking projects our organisation has funded to help reduce the impact of macular disease.

    New $100,000 research grant launched to support people with macular disease in regional and rural Australia 

    The launch of the new Elisabeth Macdonald Memorial Award coincides with World Sight Day (9 October 2025) and marks the beginning of MDFA’s 25th anniversary year. 

    Macular Disease Foundation Australia welcomes Federal Government cost increase freeze on PBS medicines 

    Affording sight-saving treatments and support is a challenge faced by many people in the macular disease community.

    Loading...